Andrea Costantino

Scopus Publications

Oral Immunotherapy-Induced Changes in IgE, IgG, and IgA: A Review of Antibody Isotype Shifts and Their Clinical Relevance in Food Allergy
Giovanni Lasagni, Laura Vetrugno, Chiara Maria Maggiore, Chiara Galassetti, Giulia Di Colo, Francesco Pavan, Andrea Costantino, Lorenzo Dagna
Antibodies, 2026
Background: Food allergy is a growing public health concern, and oral immunotherapy (OIT) has emerged as a promising approach to induce desensitization and potentially sustained unresponsiveness to allergenic foods. Changes in humoral immunity, particularly in allergen-specific immunoglobulin levels, play a central role in the immunological mechanisms underlying OIT. This review aims to summarize the current evidence on how OIT modulates allergen-specific immunoglobulin E (IgE), G (IgG) and A (IgA) responses in individuals with food allergy. Methods: We conducted a review of original research articles reporting longitudinal data on allergen-specific IgE, IgG, and/or IgA in patients undergoing OIT for common food allergens. Results: OIT was consistently associated with a transient increase in allergen-specific IgE levels during early phases, followed by a gradual decline. In contrast, Allergen-specific IgG4 levels showed a robust and sustained increase, correlating with desensitization and proposed to function as blocking antibodies. Several studies also reported an increase in allergen-specific IgA, particularly secretory IgA at mucosal sites, suggesting a potential role in enhancing mucosal tolerance and immune exclusion of allergens. Conclusions: Humoral immune responses during OIT are characterized by distinct and dynamic changes in immunoglobulin patterns. In particular, the rise in IgG4 and, in some cases, IgA suggests a role in promoting tolerance. Monitoring these biomarkers may offer insights into treatment efficacy and support individualized approaches to OIT.
Double-balloon enteroscopy evaluation and surveillance in patients with short bowel syndrome
Lucia Scaramella, Andrea Sorge, Gian Eugenio Tontini, Elia Fracas, Veronica Smania, Andrea Costantino, Tommaso Pessarelli, Marco Michelon, Matilde Topa, Ettore Corradi, Paola Onida, Annalisa Mascheroni, Livia Gallitelli, Daniela Milani, Nicoletta Nandi, Maurizio Vecchi, Luca Elli
Therapeutic Advances in Gastroenterology, 2026
Background: Safety and usefulness of double-balloon enteroscopy (DBE) in patients with short bowel syndrome (SBS) are unknown. DBE could be effective in exploring the residual small bowel (SB) entirely, in monitoring patients receiving teduglutide (TED) treatment and, if necessary, could be operative. Objective: This study aimed to assess the safety, feasibility, and efficacy of enteroscopy in SBS patients. Design: Single center, retrospective. Methods: We collected data on patients with SBS patients undergoing DBE from December 2019 to October 2023. We analyzed the technical success total enteroscopy rates, adverse events, diagnostic yield, and residual SB length measurement. Results: A total of 12 SBS patients (8 females, median age at first enteroscopy, 66 years, interquartile range (IQR) 58–79) were included; among them, 10 received TED therapy (median interval from TED prescription to DBE surveillance 9.1 months (IQR 3.2–32.9)). Overall, 15 DBE procedures (3 retrograde) were performed, all of which were technically successful and completed without adverse events. The overall diagnostic yield was 60% for relevant findings, defined as conditions unknown before DBE. No SB malignancies were detected during the study period. In 80% of cases, a complete visualization of the SB was obtained with a reevaluation of the SB length. The median depth of maximal insertion was 85 cm (IQR 50–187). Conclusion: DBE is feasible, safe, and effective in SBS patients. Total enteroscopy can be frequently achieved with a single approach in these patients, allowing easy diagnostic and oncologic surveillance for SB and colonic malignancy.
The Near-Fatal Bath: A Case Report With Literature Review of Diagnosis and Management of Cannabinoid Hyperemesis Syndrome
Nicola Siragusa, Andrea Costantino, Luisa Spina, Maurizio Vecchi
Case Reports in Medicine, 2026
Cannabinoid Hyperemesis Syndrome (CHS) is a severe condition associated with chronic cannabis use, characterized by cyclic vomiting, abdominal pain, and compulsive hot baths for symptom relief. We present the case of a 35‐year‐old male with at least a decade‐long history of cannabis use who presented with recurrent episodes of vomiting and dehydration. He experienced a potentially fatal episode of hypothermia and cardiac arrest after losing consciousness during a prolonged hot bath. Despite extensive diagnostic evaluations after many years, CHS was not identified until it was confirmed based on the Rome IV clinical criteria and elevated urinary cannabinoid levels (449 ng/mL). Management included rehydration, parenteral nutrition, and capsaicin cream targeting the transient receptor potential vanilloid Type 1 (TRPV1), as traditional antiemetics were ineffective, in conjunction with cannabis cessation. This case highlights the need for early recognition of CHS to prevent severe complications and avoid unnecessary diagnostic investigations. Prolonged cannabis abstinence remains the only definitive treatment, requiring a multidisciplinary approach. Increased awareness among clinicians is essential for timely diagnosis and appropriate management.
The ballooned stomach: A hidden vascular threat
Nicola Siragusa, Andrea Costantino, Luisa Spina, Maurizio Vecchi
Digestive and Liver Disease, 2025
Assessment of nutritional status and eating behaviours in patients with chronic inflammatory bowel disease: a pilot study
Alice Scricciolo, Vincenza Lombardo, Karla Amada Bascuñán, Magdalena Araya, Luca Elli, Andrea Costantino, Rachele Gori, Giulia Gilberti, Flavio Caprioli, Gian Eugenio Tontini, Maurizio Vecchi, Federica Mascaretti, Luisa Doneda, Valentina Meschia, Leda Roncoroni
European Journal of Clinical Nutrition, 2025
The Effectiveness of Yoga for Irritable Bowel Syndrome: A Systematic Review
Francesco Pavan, Sunil Singh Yadav, Andrea Costantino, Alessandra Dell'Era, Monic Mastroianni, Massimiliano Buoli
Comprehensive Physiology, 2025
Background Irritable Bowel Syndrome (IBS) is a common functional gastrointestinal disorder affecting 5%–10% of the global population and is characterized by recurrent abdominal pain and dysregulation of bowel movements. Many patients do not benefit from full remission of symptoms by conventional treatments. Recently, yoga has demonstrated its potential benefits in various medical conditions including IBS, as a result of its effect on the gut‐brain axis. This systematic review evaluates the effectiveness of yoga for the management of IBS. Methods We conducted a comprehensive literature search in PubMed and Scopus until March 2025 to identify studies on yogic posture, pranayama, and meditation in IBS. After excluding reviews, case reports, and studies not meeting age or design criteria, 10 studies were included. These were evaluated for methodological quality and classified as randomized controlled trials (RCTs) or non‐controlled trials. We analyzed outcomes related to gastrointestinal symptoms, quality of life, and psychological symptoms and examined the type of yoga administered. Results Yoga interventions led to amelioration of gastrointestinal symptoms, decreased anxiety and depression, and enhanced quality of life compared to usual care or wait‐list controls. Of note, the studies that fixed the change in the IBS Symptom Severity Scale scores as the primary outcome showed a moderate‐large effect of yoga on the improvement of symptoms compared to controls (Cohen's d range: 0.37–3.60). Conclusion These preliminary findings suggest that yoga could favorably influence both the physical and psychological aspects of IBS. However, high‐quality larger sample studies are needed to confirm the findings reported in the review.
The Role of Age at Onset on the Clinical Course and Biochemical Parameters of Anorexia Nervosa
Lorenzo Ferrario, Andrea Costantino, Letizia Maria Affaticati, Massimo Clerici, Antonios Dakanalis, Enrico Capuzzi, Massimiliano Buoli
Journal of Personalized Medicine, 2025
Background: Anorexia nervosa (AN) has the highest mortality rate among psychiatric disorders, making early diagnosis and tailored management crucial. This study aimed to evaluate the impact of age at onset (AAO)—childhood/adolescence versus adulthood—on the clinical course and associated biochemical parameters. Methods: Seventy-six female patients with AN were divided into two groups based on AAO (<18 years vs. ≥18 years). Group comparisons were performed using t-tests for continuous variables and χ2 tests for categorical variables. Correlation analyses assessed associations between AAO and continuous variables. Significant findings were entered into regression models, including a binary logistic regression with AAO as the dependent variable and a linear regression with significant correlations as predictors. Results: The early-onset group showed significantly higher potassium levels and a lower sodium/potassium ratio (Na+/K+) compared with the late-onset group (potassium: t = 0.93, p < 0.01; Na+/K+: t = 3.39, p < 0.01). AAO was strongly inversely correlated with potassium levels (r = −0.75, p < 0.01) and positively correlated with cholesterol (r = 0.574, p < 0.01) and Na+/K+ (r = 0.78, p = 0.01). Binary logistic regression correctly classified 87% of cases, showing that lower Na+/K+ was associated with earlier onset (OR = 2.23, p = 0.03). Linear regression confirmed significant associations of AAO with cholesterol levels (B = 0.07, p = 0.02) and Na+/K+ (B = 1.68, p < 0.01). Conclusions: AAO in AN is strongly associated with specific biochemical parameters. Early-onset patients exhibit more severe electrolyte imbalances, while late-onset cases show higher cholesterol levels, suggesting increased cardiovascular risk. These findings emphasize the importance of personalized treatment approaches according to AAO, although further studies are warranted to confirm these results.
Dramatic endoscopic presentation of Ileal HHV-6 enteritis in a patient treated for graft-versus-host disease
Fabrizio Santagata, Andrea Costantino, Fabio Serpenti, Gian Eugenio Tontini
Digestive and Liver Disease, 2025
The Ten Dietary Commandments for Patients with Irritable Bowel Syndrome: A Narrative Review with Pragmatic Indications
Nicola Siragusa, Gloria Baldassari, Lorenzo Ferrario, Laura Passera, Beatrice Rota, Francesco Pavan, Fabrizio Santagata, Mario Capasso, Claudio Londoni, Guido Manfredi, Danilo Consalvo, Giovanni Lasagni, Luca Pozzi, Vincenza Lombardo, Federica Mascaretti, Alice Scricciolo, Leda Roncoroni, Luca Elli, Maurizio Vecchi, Andrea Costantino
Nutrients, 2025
Irritable bowel syndrome (IBS) is a gut–brain axis chronic disorder, characterized by recurrent abdominal pain and altered bowel habits in the absence of organic pathology. Nutrition plays a central role in symptom management, yet no single dietary strategy has demonstrated universal effectiveness. This narrative review critically evaluates current nutritional approaches to IBS. The low-Fermentable Oligo-, Di-, Mono-saccharides and Polyols (FODMAP) diet is the most extensively studied and provides short-term symptom relief, but its long-term effects on microbiota diversity remain concerning. The Mediterranean diet, due to its anti-inflammatory and prebiotic properties, offers a sustainable, microbiota-friendly option; however, it has specific limitations in the context of IBS, particularly due to the adverse effects of certain FODMAP-rich foods. A gluten-free diet may benefit individuals with suspected non-celiac gluten sensitivity, although improvements are often attributed to fructan restriction and placebo and nocebo effects. Lactose-free diets are effective in patients with documented lactose intolerance, while a high-soluble-fiber diet is beneficial for constipation-predominant IBS. IgG-based elimination diets are emerging but remain controversial and require further validation. In this review, we present the 10 dietary commandments for IBS, pragmatic and easily retained recommendations. It advocates a personalized, flexible, and multidisciplinary management approach, avoiding rigidity and standardized protocols, with the aim of optimizing adherence, symptom mitigation, and health-related quality of life. Future research should aim to evaluate, in real-world clinical settings, the impact and applicability of the 10 dietary commandments for IBS in terms of symptom improvement and quality of life
High Rate of Antibody Response to Multiple Doses of the COVID-19 Vaccine in Liver Transplant Recipients: Analysis of Predictive Factors
Nunzio Zignani, Andrea Costantino, Michele Sagasta, Clara Dibenedetto, Riccardo Perbellini, Sara Uceda Renteria, Pietro Lampertico, Maria Francesca Donato
Vaccines, 2025
Background: The COVID-19 pandemic highlighted the vulnerability of immunocompromised individuals, including liver transplant recipients (LTRs), who often exhibit reduced vaccine immunogenicity. While initial vaccine doses and subsequent boosters improved immune response, LTRs were prioritized for vaccination. Studies have shown increased antibody response after each booster dose. Vaccine hesitancy, defined as delayed or refused vaccination despite availability, poses a public health challenge, often fueled by misinformation. This study aimed to evaluate anti-spike antibody responses in vaccinated LTRs after two initial doses and at least one booster, also assessing adherence to subsequent doses. Methods: We conducted a retrospective observational study at a transplant center in Milan, Italy, between January 2021 and December 2023. LTRs who had received four or more doses of mRNA vaccines (Pfizer or Moderna) were included. Anti-spike antibody levels were measured 60–80 days after each dose. Data on vaccination status were collected in January 2024. Statistical analysis was performed to compare antibody responses and identify predictive factors. Results: LTRs showed a significant increase in anti-spike antibody responses after the first booster compared to the second dose with a trend versus a further increase following the fourth dose in a subgroup of the patients receiving two booster doses. However, adherence to booster doses decreased over time. In LTRs, predictors of a weaker response after the second dose were chronic kidney disease and metabolic etiology at transplant. Conclusions: The study highlighted that in LTRs, multiple doses of the COVID-19 vaccine led to a continuous increase in anti-spike antibody responses. The progressive decline in adherence of LTRs “to further booster doses” should be related to the fact that after the spread of vaccination programs worldwide, COVID-19 is still a current infection, but it is much less severe than before.
Abdominal and Bowel Ultrasound Knowledge Among Young Gastroenterologists: Results of an Italian Survey
Fabio Cortellini, Anna Fichera, Alessia Dalila Guarino, Lucrezia Laterza, Luigina Vanessa Alemanni, Loris Lopetuso, Giovanni Marasco, Andrea Costantino
Journal of Clinical Medicine, 2025
Is IBS a Food Allergy? Confocal Laser Endomicroscopy Findings in Patients with IBS: A Narrative Review
Francesco Pavan, Andrea Costantino, Gian Eugenio Tontini, Luca Elli, Nicola Siragusa, Giovanni Lasagni, Marco Dubini, Alice Scricciolo, Maurizio Vecchi
Applied Sciences Switzerland, 2025
Microbiota-gut-brain axis: towards a microbiota-centred approach for irritable bowel syndrome
Andrea Costantino, Gennaro Tagliamonte, Marcello Romeo
Journal of Biological Research Italy, 2025
The Epidemiology and Clinical Management of Short Bowel Syndrome and Chronic Intestinal Failure in Crohn’s Disease in Italy: An IG-IBD Survey
Tommaso Pessarelli, Matilde Topa, Andrea Sorge, Nicoletta Nandi, Daniela Pugliese, Fabio Salvatore Macaluso, Ambrogio Orlando, Simone Saibeni, Andrea Costantino, Francesco Stalla, Valentina Zadro, Lucia Scaramella, Maurizio Vecchi, Flavio Caprioli, Luca Elli
Nutrients, 2024
Functional Abdominal Bloating and Gut Microbiota: An Update
Salvatore Crucillà, Federico Caldart, Marco Michelon, Giovanni Marasco, Andrea Costantino
Microorganisms, 2024
Reproducibility and accuracy of a pocket-size ultrasound device in assessing liver steatosis
Andrea Costantino, Alessandra Piagnani, Riccardo Caccia, Andrea Sorge, Marco Maggioni, Riccardo Perbellini, Francesca Donato, Roberta D'Ambrosio, Nicole Piazza O Sed, Luca Valenti, Daniele Prati, Maurizio Vecchi, Pietro Lampertico, Mirella Fraquelli
Digestive and Liver Disease, 2024
Superior predictive value of transmural over endoscopic severity for colectomy risk in ulcerative colitis: a multicentre prospective cohort study
Nicole Piazza O Sed, Daniele Noviello, Elisabetta Filippi, Francesco Conforti, Federica Furfaro, Mirella Fraquelli, Andrea Costantino, Silvio Danese, Maurizio Vecchi, Gionata Fiorino, Mariangela Allocca, Flavio Caprioli
Journal of Crohn S and Colitis, 2024
Human cytomegalovirus-related gastrointestinal disease after kidney transplantation: A systematic review
Ilaria Elena Zais, Alessandro Sirotti, Samuele Iesari, Edoardo Campioli, Andrea Costantino, Serena Delbue, Andrea Collini, Andrea Guarneri, Federico Ambrogi, Roberto Cacciola, Mariano Ferraresso, Evaldo Favi
Clinical Transplantation, 2024
Attitudes towards Vaccinations in a National Italian Cohort of Patients with Inflammatory Bowel Disease
Andrea Costantino, Marco Michelon, Daniele Noviello, Fabio Salvatore Macaluso, Salvo Leone, Nicole Bonaccorso, Claudio Costantino, Maurizio Vecchi, Flavio Caprioli
Vaccines, 2023
Depressive and Anxiety Disorders in Patients with Inflammatory Bowel Diseases: Are There Any Gender Differences?
Elia Fracas, Andrea Costantino, Maurizio Vecchi, Massimiliano Buoli
International Journal of Environmental Research and Public Health, 2023
Evaluation of a Single Determination of Gluten Immunogenic Peptides in Urine from Unaware Celiac Patients to Monitor Gluten-Free Diet Adherence
Vincenza Lombardo, Alice Scricciolo, Andrea Costantino, Luca Elli, Giorgia Legnani, Ángel Cebolla, Luisa Doneda, Federica Mascaretti, Maurizio Vecchi, Leda Roncoroni
Nutrients, 2023
Clinical features of type 1 and 2 refractory celiac disease: Results from a large cohort over a decade
Luca Elli, Pietro Soru, Leda Roncoroni, Francesca Gaia Rossi, Valeria Ferla, Luca Baldini, Nicoletta Nandi, Lucia Scaramella, Alice Scricciolo, Alessandro Rimondi, Nicola Fusco, Giorgio Alberto Croci, Umberto Gianelli, Lilla Cro, Marzia Barbieri, Vincenza Lombardo, Andrea Costantino, Valentina Vaira, Stefano Ferrero, Gian Eugenio Tontini, Giulio Barigelletti, Sabrina Fabiano, Luisa Doneda, Maurizio Vecchi
Digestive and Liver Disease, 2023
Early Ultrasound Response and Progressive Transmural Remission After Treatment With Ustekinumab in Crohn's Disease
Torsten Kucharzik, Rune Wilkens, Maria-Antonietta D’Agostino, Giovanni Maconi, Manuela Le Bars, Marjolein Lahaye, Ivana Bravatà, Maciej Nazar, Lioudmila Ni, Elena Ercole, Mariangela Allocca, Naděžda Machková, Floris A.E. de Voogd, Carolina Palmela, Rose Vaughan, Christian Maaser, Tomas Grega, Ivana Niangova, Rudolf Repak, Petra Matejkova, Radka Vanickova, Juel Mie Agerbæk, Annett Cannon, Vittorio Giuliano, Christoph Antoni, Jürgen Büning, Michael Gebel, Martin Grewe, Sebastian Küpper, Nikolas Ryschka, Andrej Potthoff, Wolfgang Reindl, Karolin Schliwa, Martin Schulz, Hermann Schulze, Markus Krankenhaus, Marco Affronti, Maria Laura, Christina Bezzio, Flaminia Cavallaro, Marina Coletta, Andrea Costantino, Federico Furfaro, Fabrizio Pizzolante, Steven Bots, Robert De Knegt, Ivan Bunganic, Zdenek Opravil, Joaquin Poza, Jordi Rimola, Cristina Suarez Ferrer
Clinical Gastroenterology and Hepatology, 2023
Bulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertension
Elisabetta Degasperi, Maria Paola Anolli, Sara Colonia Uceda Renteria, Dana Sambarino, Marta Borghi, Riccardo Perbellini, Caroline Scholtes, Floriana Facchetti, Alessandro Loglio, Sara Monico, Mirella Fraquelli, Andrea Costantino, Ferruccio Ceriotti, Fabien Zoulim, Pietro Lampertico
Journal of Hepatology, 2022
The low-FODMAP diet and the gluten-free diet in the management of functional abdominal bloating and distension
Tommaso Pessarelli, Andrea Sorge, Luca Elli, Andrea Costantino
Frontiers in Nutrition, 2022
A practical guide to the proper prescription of physical activity in patients with irritable bowel syndrome
Andrea Costantino, Tommaso Pessarelli, Marco Vecchiato, Maurizio Vecchi, Guido Basilisco, Andrea Ermolao
Digestive and Liver Disease, 2022
Hesitancy toward the Full COVID-19 Vaccination among Kidney, Liver and Lung Transplant Recipients in Italy
Andrea Costantino, Letizia Morlacchi, Maria Francesca Donato, Andrea Gramegna, Elisa Farina, Clara Dibenedetto, Mariarosaria Campise, Matteo Redaelli, Marta Perego, Carlo Alfieri, Francesco Blasi, Pietro Lampertico, Evaldo Favi
Vaccines, 2022
Diagnostic management of patients reporting symptoms after wheat ingestion
Andrea Costantino, Gloria Maria Aversano, Giovanni Lasagni, Veronica Smania, Luisa Doneda, Maurizio Vecchi, Leda Roncoroni, Elide Anna Pastorello, Luca Elli
Frontiers in Nutrition, 2022
Use of a proline-specific endopeptidase to reintroduce gluten in patients with non-coeliac gluten sensitivity: A randomized trial
A. Scricciolo, V. Lombardo, L. Elli, K.A. Bascuñán, L. Doneda, F. Rinaldi, D. Pinto, M. Araya, A. Costantino, M. Vecchi, L. Roncoroni
Clinical Nutrition, 2022
Vaccination Status and Attitudes towards Vaccines in a Cohort of Patients with Celiac Disease
Andrea Costantino, Marco Michelon, Leda Roncoroni, Luisa Doneda, Vincenza Lombardo, Claudio Costantino, Maurizio Vecchi, Luca Elli
Vaccines, 2022
Capsule enteroscopy versus small-bowel ultrasonography for the detection and differential diagnosis of intestinal diseases
Luca Elli, Erica Centorrino, Andrea Costantino, Maurizio Vecchi, Stefania Orlando, Mirella Fraquelli
Clinical Endoscopy, 2022
Reproducibility and diagnostic accuracy of pocket-sized ultrasound devices in ruling out compensated cirrhosis of mixed etiology
Andrea Costantino, Alessandra Piagnani, Nicoletta Nandi, Valentina Sciola, Marco Maggioni, Francesca Donato, Maurizio Vecchi, Pietro Lampertico, Giovanni Casazza, Mirella Fraquelli
European Radiology, 2022
Letter of Reply to "Response to: COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association"
Andrea Costantino, Daniele Noviello, Claudio Costantino, Maurizio Vecchi, Flavio Caprioli
Inflammatory Bowel Diseases, 2022
COVID-19 Vaccination Willingness and Hesitancy in Patients with Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association
Andrea Costantino, Daniele Noviello, Francesco Simone Conforti, Marina Aloi, Alessandro Armuzzi, Fabrizio Bossa, Ferdinando Ficari, Salvo Leone, Francesco Manguso, Giammarco Mocci, Ambrogio Orlando, Loris Pironi, Simona Radice, Fernando Rizzello, Alessandra Tongiorgi, Claudio Costantino, Maurizio Vecchi, Flavio Caprioli
Inflammatory Bowel Diseases, 2022
Functional gastrointestinal and somatoform symptoms five months after SARS-CoV-2 infection: A controlled cohort study
Daniele Noviello, Andrea Costantino, Antonio Muscatello, Alessandra Bandera, Dario Consonni, Maurizio Vecchi, Guido Basilisco
Neurogastroenterology and Motility, 2022
Nutrition in Patients with Inflammatory Bowel Diseases: A Narrative Review
Leda Roncoroni, Rachele Gori, Luca Elli, Gian Eugenio Tontini, Luisa Doneda, Lorenzo Norsa, Marialaura Cuomo, Vincenza Lombardo, Alice Scricciolo, Flavio Caprioli, Andrea Costantino, Lucia Scaramella, Maurizio Vecchi
Nutrients, 2022
Interaction between Lifestyle Changes and PNPLA3 Genotype in NAFLD Patients during the COVID-19 Lockdown
Felice Cinque, Annalisa Cespiati, Rosa Lombardi, Andrea Costantino, Gabriele Maffi, Francesca Alletto, Lucia Colavolpe, Paolo Francione, Giovanna Oberti, Erika Fatta, Cristina Bertelli, Giordano Sigon, Paola Dongiovanni, Maurizio Vecchi, Silvia Fargion, Anna Ludovica Fracanzani
Nutrients, 2022
Agreement between real-time elastography and delayed enhancement magnetic resonance enterography on quantifying bowel wall fibrosis in Crohn's disease
Stefano Mazza, Francesco Simone Conforti, Laura Virginia Forzenigo, Nicole Piazza, Roberto Bertè, Andrea Costantino, Mirella Fraquelli, Marina Coletta, Jordi Rimola, Maurizio Vecchi, Flavio Caprioli
Digestive and Liver Disease, 2022
Determinants of patient trust in gastroenterology televisits: Results of machine learning analysis: Determinants of Patient Trust in Televisits
Andrea Costantino, Flavio Caprioli, Luca Elli, Leda Roncoroni, Davide Stocco, Luisa Doneda, Nicoletta Nandi, Francesco Simone Conforti, Daniele Noviello, Roberto Penagini, Maurizio Vecchi
Informatics in Medicine Unlocked, 2022
Evaluation of factors associated with trust in telemedicine in patients with inflammatory bowel disease during COVID-19 pandemic: a multicenter cross-sectional survey
F. Bossa, M. R. Valvano, L. Vetrone, M. Guerra, L. Lopetuso, S. Carparelli, I. Mignini, F. Cocomazzi, D. Napolitano, A. Costantino, F. Caprioli, A. Gasbarrini, F. Perri, A. Papa
European Review for Medical and Pharmacological Sciences, 2022
Anti-SARS-CoV-2 immunoglobulin profile in patients with celiac disease living in a high incidence area
Luca Elli, Federica Facciotti, Vincenza Lombardo, Alice Scricciolo, David S. Sanders, Valentina Vaira, Donatella Barisani, Maurizio Vecchi, Andrea Costantino, Lucia Scaramella, Bernardo dell'Osso, Luisa Doneda, Leda Roncoroni
Digestive and Liver Disease, 2022
COVID-19 vaccine acceptance among liver transplant recipients
Andrea Costantino, Federica Invernizzi, Erica Centorrino, Maurizio Vecchi, Pietro Lampertico, Maria Francesca Donato
Vaccines, 2021
Correct use of telemedicine in gastroenterology, hepatology, and endoscopy during and after the COVID-19 pandemic: Recommendations from the Italian association of hospital gastroenterologists and endoscopists (AIGO)
Andrea Costantino, Francesco Bortoluzzi, Mauro Giuffrè, Roberto Vassallo, Luigi Maria Montalbano, Fabio Monica, Daniele Canova, Davide Checchin, Paolo Fedeli, Riccardo Marmo, Luca Elli
Digestive and Liver Disease, 2021
Covid-19 vaccine: A survey of hesitancy in patients with celiac disease
Andrea Costantino, Matilde Topa, Leda Roncoroni, Luisa Doneda, Vincenza Lombardo, Davide Stocco, Andrea Gramegna, Claudio Costantino, Maurizio Vecchi, Luca Elli
Vaccines, 2021
Milan ultrasound criteria are accurate in assessing disease activity in ulcerative colitis: external validation
Mariangela Allocca, Elisabetta Filippi, Andrea Costantino, Stefanos Bonovas, Gionata Fiorino, Federica Furfaro, Laurent Peyrin-Biroulet, Mirella Fraquelli, Flavio Caprioli, Silvio Danese
United European Gastroenterology Journal, 2021
Nutritional and Gastroenterological Monitoring of Patients With Celiac Disease During COVID-19 Pandemic: The Emerging Role of Telemedicine and Point-of-Care Gluten Detection Tests
Andrea Costantino, Leda Roncoroni, Daniele Noviello, Nicoletta Nandi, Vincenza Lombardo, Alice Scricciolo, Lucia Scaramella, Maurizio Vecchi, Luca Elli
Frontiers in Nutrition, 2021
Trust in telemedicine from IBD outpatients during the COVID-19 pandemic
A. Costantino, D. Noviello, S. Mazza, R. Berté, F. Caprioli, M. Vecchi
Digestive and Liver Disease, 2021
Elastography After Treatment and During Follow-Up
Mirella Fraquelli, Ilaria Fanetti, Andrea Costantino
Elastography of the Liver and Beyond, 2021
Case 3: Congestive Hepatopathy with High Liver and Spleen Stiffness in a 17 Years Old Male Patient
Andrea Costantino, Mirella Fraquelli, Massimo Chessa, Vincenzo La Mura
Elastography of the Liver and Beyond, 2021
Is pocket-size ultrasound a reliable tool for bowel investigation? A study on its feasibility, reproducibility and diagnostic accuracy
Andrea Costantino, Mariangela Giunta, Giovanni Casazza, Silvia Arona, Agostino Colli, Dario Conte, Maurizio Vecchi, Mirella Fraquelli
Digestive and Liver Disease, 2020
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma
Giuseppe Cabibbo, Salvatore Petta, Marco Barbàra, Gabriele Missale, Roberto Virdone, Eugenio Caturelli, Fabio Piscaglia, Filomena Morisco, Antonio Colecchia, Fabio Farinati, Edoardo Giannini, Franco Trevisani, Antonio Craxì, Massimo Colombo, Calogero Cammà, and
Liver International, 2017
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma
Anna Pecorelli, Barbara Lenzi, Annagiulia Gramenzi, Francesca Garuti, Fabio Farinati, Edoardo G. Giannini, Francesca Ciccarese, Fabio Piscaglia, Gian Lodovico Rapaccini, Maria Di Marco, Eugenio Caturelli, Marco Zoli, Franco Borzio, Rodolfo Sacco, Giuseppe Cabibbo, Martina Felder, Filomena Morisco, Antonio Gasbarrini, Gianluca Svegliati Baroni, Francesco G. Foschi, Elisabetta Biasini, Alberto Masotto, Roberto Virdone, Mauro Bernardi, Franco Trevisani, and
Liver International, 2017
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon
S. Petta, G. Cabibbo, M. Barbara, S. Attardo, L. Bucci, F. Farinati, E. G. Giannini, F. Tovoli, F. Ciccarese, G. L. Rapaccini, M. Di Marco, E. Caturelli, M. Zoli, F. Borzio, R. Sacco, R. Virdone, F. Marra, M. Felder, F. Morisco, L. Benvegnù, A. Gasbarrini, G. Svegliati-Baroni, F. G. Foschi, A. Olivani, A. Masotto, G. Nardone, A. Colecchia, M. Persico, V. Boccaccio, A. Craxì, S. Bruno, F. Trevisani, C. Cammà, and
Alimentary Pharmacology and Therapeutics, 2017
Clinical course and genetic susceptibility of primary biliary cirrhosis: Analysis of a prospective cohort
Piero Luigi Almasio, Anna Licata, Marcello Maida, Fabio Salvatore Macaluso, Andrea Costantino, Nicola Alessi, Stefania Grimaudo, Giulia Accardi, Calogero Caruso, Antonio Craxi
Hepatitis Monthly, 2016
Years of life that could be saved from prevention of hepatocellular carcinoma
A. Cucchetti, F. Trevisani, L. Bucci, M. Ravaioli, F. Farinati, E. G. Giannini, F. Ciccarese, F. Piscaglia, G. L. Rapaccini, M. Di Marco, E. Caturelli, M. Zoli, F. Borzio, R. Sacco, M. Maida, M. Felder, F. Morisco, A. Gasbarrini, S. Gemini, F. G. Foschi, G. Missale, A. Masotto, A. Affronti, M. Bernardi, A. D. Pinna, and
Alimentary Pharmacology and Therapeutics, 2016
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma
Fabio Farinati, Alessandro Vitale, Gaya Spolverato, Timothy M. Pawlik, Teh-la Huo, Yun-Hsuan Lee, Anna Chiara Frigo, Anna Giacomin, Edoardo G. Giannini, Francesca Ciccarese, Fabio Piscaglia, Gian Lodovico Rapaccini, Mariella Di Marco, Eugenio Caturelli, Marco Zoli, Franco Borzio, Giuseppe Cabibbo, Martina Felder, Rodolfo Sacco, Filomena Morisco, Elisabetta Biasini, Francesco Giuseppe Foschi, Antonio Gasbarrini, Gianluca Svegliati Baroni, Roberto Virdone, Alberto Masotto, Franco Trevisani, Umberto Cillo, and
Plos Medicine, 2016
Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study
Fabio Piscaglia, Gianluca Svegliati-Baroni, Andrea Barchetti, Anna Pecorelli, Sara Marinelli, Claudio Tiribelli, Stefano Bellentani, and
Hepatology, 2016
Recurrence of hepatocellular carcinoma after liver transplantation: An update
Alessandra Mazzola, Andrea Costantino, Salvatore Petta, Tommaso Vincenzo Bartolotta, Maurizio Raineri, Rodolfo Sacco, Giuseppe Brancatelli, Calogero Cammà, Giuseppe Cabibbo
Future Oncology, 2015

Andrea Costantino

EDUCATION

RESEARCH INTERESTS

Scopus Publications

RECENT SCHOLAR PUBLICATIONS

MOST CITED SCHOLAR PUBLICATIONS

GRANT DETAILS